MedTrace Logo

Seaweed-Derived Mineral-Rich Nutraceuticals in Cognition

NCT02913287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-06-27

No results posted yet for this study

Summary

The aim of the overall project is to investigate the potential of a combination of commercially available nutraceuticals produced by Marigot Ltd (natural seawater derived mineral-rich AquaminMG and seaweed-derived mineral-rich food supplement AquaminTM (FDA GRAS 000028) isolated from Lithothamnion species), as safe and effective supplements to promote cognition in the aged brain.

Conditions

  • Cognition

Interventions

DIETARY_SUPPLEMENT

Aquamin/Aquamin MG

Marine-based nutraceutical

OTHER

Maltodextrin Placebo

Maltodextrin Placebo

Sponsors & Collaborators

  • University College Cork

    lead OTHER

Principal Investigators

  • Yvonne Nolan · University College Cork

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-15
Primary Completion
2016-11-09
Completion
2017-01-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02913287 on ClinicalTrials.gov